Medimmune Archives

AstraZeneca’s Joe Sanchez Shares Vision for Growing the BioHealth Capital Region

Published on : February 16, 2021February 16, 2021 Published by : Steven Surdez

When AstraZeneca (AZ) announced in 2019 that it was officially retiring the MedImmune brand, questions naturally arose about whether the U.K. pharma giant would continue the legacy MedImmune support for the BioHealth Capital Region’s (BHCR) life science ecosystem.

Top Biopharma Talent Acquisition Experts Share Strategies for Hiring and Retaining Employees in 2020

Published on : November 3, 2020November 3, 2020 Published by : Steven Surdez

The biotech industry continues to grow rapidly across the nation, especially in the BHCR. The region’s strategy for hiring and retaining employees is a key driver of the BHCR’s steady, sustained growth.

Former MedImmune Employees Leading In the BioHealth Capital Region and Beyond

Published on : June 29, 2020September 16, 2020 Published by : Andy Eckert

Former MedImmune Employees Leading In the BioHealth Capital Region and Beyond In a recent conversation someone shared the quote “You can’t throw a stone in the BioHealth Capital Region and [….]

5 Questions with Stephanie Duatschek, Biopharma Executive Management Consultant

Published on : June 1, 2020September 28, 2020 Published by : Andy Eckert

5 Questions with Stephanie Duatschek, Biopharma Executive Management Consultant “5 Questions With……” is a new BioBuzz series where we reach out to interesting people in the BioHealth Capital Region to [….]

5 Questions with Jennifer Butler, Executive Vice President and General Manager of Innate Pharma U.S.

Published on : May 26, 2020September 28, 2020 Published by : Andy Eckert

5 Questions with Jennifer Butler, Executive Vice President and General Manager of Innate Pharma U.S. “5 Questions With……” is a new BioBuzz series where we reach out to interesting people [….]

5 Questions With John Trainer, CFO, NexImmune, Inc.

Published on : May 11, 2020September 28, 2020 Published by : Andy Eckert

5 Questions With John Trainer, CFO, NexImmune, Inc. “5 Questions With……” is a new BioBuzz series where we reach out to interesting people in the BioHealth Capital Region to share [….]

BHCR Retains #4 Ranking in GEN’s Top 10 U.S. Biopharma Clusters – Here’s Why.

Published on : September 24, 2019September 26, 2019 Published by : Chris Frew

BHCR Retains #4 Ranking in GEN’s Top 10 U.S. Biopharma Clusters – Here’s Why. “Top 3 By 2023” has been the slogan for the Biohealth Capital Region (BHCR) over the [….]

BioHealth Capital Region is Entering Period of “Creative Destruction” at Perfect Time

Published on : March 13, 2019March 14, 2019 Published by : Steven Surdez

BioHealth Capital Region is Entering Period of “Creative Destruction” at Perfect Time March 12, 2019 In 1942, Austrian economist Joseph Schumpeter wrote, “ …industrial mutation—if I may use that biological [….]

Viela Bio’s Spinout Story Reveals A Roadmap for Growth Ahead

Published on : November 6, 2018November 14, 2018 Published by : Chris Frew

Viela Bio’s Spinout Story Reveals A Roadmap for Growth Ahead November 6, 2018 In order: Elizabeth Parsons (Member, Mintz Levin), Aaron Ren (Head of BD and Operations, Viela Bio), Christian [….]

Q&A with Jaime Rodriguez-Canales, M.D., FEBP – The importance of Multiplex Immunofluorescence in the field of Immune-Oncology

Published on : October 30, 2018March 15, 2019 Published by : Chris Frew

Q&A with Jaime Rodriguez-Canales, M.D., FEBP Dr. Rodriguez-Canales is a Senior Pathologist at MedImmune, and Course Director for the recent Multiplex Immunofluorescence in Immune-Oncology Symposium, a Bio-Trac program cosponsored by [….]